Key result
Early anti-inflammatory therapy and GDMT normalizes cardiac function in a Campylobacter jejuni-associated myocarditis case.
Why the study?
Campylobacter jejuni is a common cause of bacterial gastroenteritis but is rarely associated with extraintestinal cardiac manifestations such as myocarditis.
Case Report (n=1)
No
This case highlights that early initiation of guideline-directed heart failure therapy and anti-inflammatory treatment can lead to rapid recovery of myocardial function in C. jejuni-associated myocarditis.
Suggests possible benefit of early therapy in rare infectious myocarditis; leaves open confirmation in prospective studies.
Acute myocarditis involves inflammatory injury to the myocardium and may develop in association with diverse infectious or non-infectious triggers. Campylobacter jejuni (C. jejuni), a leading cause of bacterial gastroenteritis worldwide, is rarely associated with extraintestinal cardiac manifestations. This report describes a case of C. jejuni-associated myocarditis in a 19-year-old male patient who presented with severe central chest pain, diaphoresis, and fever three days following an episode of acute gastroenteritis. Initial investigations revealed significantly elevated cardiac biomarkers and preserved renal function. Stool polymerase chain reaction confirmed C. jejuni infection. Transthoracic echocardiography demonstrated a reduction in left ventricular (LV) systolic function with an ejection fraction (EF) of 43% and global hypokinesis. Cardiac magnetic resonance imaging (MRI) confirmed the diagnosis, showing widespread edema and late gadolinium enhancement consistent with severe acute myocarditis. The patient was managed conservatively regarding the bacterial infection but received aggressive cardiac support. Treatment included anti-inflammatory therapy with colchicine and ibuprofen, alongside the initiation of guideline-directed medical therapy for heart failure, including bisoprolol, dapagliflozin, eplerenone, and ramipril. The patient showed rapid clinical improvement and was discharged after six days. Follow-up imaging at two months demonstrated normalization of cardiac function with an LVEF of 58%, and cMRI at three months confirmed resolution of the acute inflammation. This case highlights the necessity of considering myocarditis in young patients presenting with chest pain following gastrointestinal infections. It further illustrates the potential benefit of early initiation of the "four pillars" of heart failure therapy in recovering myocardial function in bacterial myocarditis.
No takes yet. Share an insight, caveat, or question.
Smadi et al. (2025) conducted a case report in Campylobacter jejuni-associated myocarditis (n=1). Anti-inflammatory and guideline-directed heart failure therapy was evaluated on Clinical and echocardiographic recovery. Early initiation of anti-inflammatory and guideline-directed heart failure therapy in a 19-year-old male with Campylobacter jejuni-associated myocarditis resulted in normalization of cardiac function at two months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: